These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28913325)

  • 21. Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Beaudoin C; Jean S; Bessette L; Ste-Marie LG; Moore L; Brown JP
    Osteoporos Int; 2016 Sep; 27(9):2835-2844. PubMed ID: 27120345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.
    Yang Y; Qiu S; Deng L; Tang X; Li X; Wei Q; Fu P
    BMC Nephrol; 2018 Oct; 19(1):269. PubMed ID: 30340537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
    Stokkers PC; Deley M; Van Der Spek M; Verberne HJ; Van Deventer SJ; Hommes DW
    Scand J Gastroenterol; 2006 Feb; 41(2):200-4. PubMed ID: 16484125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of bisphosphonate therapy in kidney transplant recipients: a systematic review and meta-analysis.
    Toth-Manikowski SM; Francis JM; Gautam A; Gordon CE
    Clin Transplant; 2016 Sep; 30(9):1090-6. PubMed ID: 27327448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
    Sebba AI
    Clin Ther; 2008 Mar; 30(3):443-52. PubMed ID: 18405784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of bisphosphonates on bone mineral density in osteopenic postmenopausal women: A systematic review and network meta-analysis of randomized controlled trials.
    Dong SL; Jiao Y; Yang HL
    Medicine (Baltimore); 2021 Aug; 100(31):e26715. PubMed ID: 34397808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Bisphosphonates on Bone Mineral Density and Fracture Rate in Patients With Osteogenesis Imperfecta: A Systematic Review and Meta-analysis.
    Shi CG; Zhang Y; Yuan W
    Am J Ther; 2016; 23(3):e894-904. PubMed ID: 25844482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.
    Sugimoto T; Shiraki M; Nakano T; Kishimoto H; Ito M; Fukunaga M; Hagino H; Sone T; Kuroda T; Nakamura T
    Curr Med Res Opin; 2013 Mar; 29(3):195-203. PubMed ID: 23259702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.
    Yang Y; Qiu S; Tang X; Li XR; Deng LH; Wei Q; Fu P
    Chin Med J (Engl); 2018 Apr; 131(7):818-828. PubMed ID: 29578126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.
    Wang Z; Han Z; Tao J; Lu P; Liu X; Wang J; Wu B; Huang Z; Yin C; Tan R; Gu M
    PLoS One; 2014; 9(9):e108106. PubMed ID: 25265508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.
    Wang C
    Am J Ther; 2017; 24(5):e544-e552. PubMed ID: 26938765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates Alleviate Bone Loss in People with Acute Spinal Cord Injury：A Systematic Review and Meta-Analysis.
    Ma Z; Ma M; He Y; Sun H; Yang B; Dong H; Wang Y
    World Neurosurg; 2023 Feb; 170():e584-e595. PubMed ID: 36410707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Cardiac Transplant Patients: A Meta-Analysis.
    Zhao J; Wang C; Hu Z
    Transplant Proc; 2015 Dec; 47(10):2957-64. PubMed ID: 26707321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
    Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
    Abitbol V; Briot K; Roux C; Roy C; Seksik P; Charachon A; Bouhnik Y; Coffin B; Allez M; Lamarque D; Chaussade S
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bisphosphonates in preventing femoral periprosthetic bone resorption after primary cementless total hip arthroplasty: a meta-analysis.
    Zhao X; Hu D; Qin J; Mohanan R; Chen L
    J Orthop Surg Res; 2015 May; 10():65. PubMed ID: 25962791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis.
    Bhandari M; Bajammal S; Guyatt GH; Griffith L; Busse JW; Schünemann H; Einhorn TA
    J Bone Joint Surg Am; 2005 Feb; 87(2):293-301. PubMed ID: 15687150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease.
    Palomba S; Orio F; Manguso F; Falbo A; Russo T; Tolino A; Tauchmanovà L; Colao A; Doldo P; Mastrantonio P; Zullo F
    Osteoporos Int; 2005 Sep; 16(9):1141-9. PubMed ID: 15928801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.